About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, March 23, 2026
Sign in / Join
Home
Disclaimer
Facebook
Instagram
Linkedin
Twitter
WhatsApp
About Us
Brands in Conversation
Academic Connect
Regional Trailblazers
Marketers in Conversation
Marketing Guru Speaks
Case Studies
Contact Us
Contribute Articles
Market Intelligence & Research
Skilling Programs
Internship
Search
Home
Tags
Granules India
Tag: Granules India
Brands in Conversation
Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)
Author
-
January 9, 2026
0
Brands in Conversation
Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)
Author
-
December 22, 2025
0
Brands in Conversation
Granules India Strengthens R&D Leadership with Two New Centres of Excellence at IIT Hyderabad’s Technology Research Park
Passionate in Marketing
-
December 2, 2025
0
Brands in Conversation
Granules Life Sciences Receives First U.S. FDA Approval for Hyderabad Facility
Passionate in Marketing
-
November 11, 2025
0
Brands in Conversation
Granules India Limited Extends Support to 1,030 TB Patients in Bhadradri Kothagudem District
Author
-
May 13, 2025
0
Brands in Conversation
Granules India Earns Gold Rating in First-Ever Corporate-Level EcoVadis Assessment Ranks in the Top 5% Globally Across All Industries
Author
-
May 7, 2025
0
Brands in Conversation
Granules India Announces Closing of Acquisition of Senn Chemicals, Strengthening Capabilities in Peptide Therapeutics and CDMO Services
Author
-
April 14, 2025
0
Brands in Conversation
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Passionate in Marketing
-
January 30, 2025
0
Brands in Conversation
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Passionate in Marketing
-
December 17, 2024
0
Brands in Conversation
Granules India Limited Honoured with Golden Peacock Award for Sustainability, Setting New Standards in Environmental Responsibility
Passionate in Marketing
-
November 15, 2024
0
1
2
Page 1 of 2